Bharat Biotech seeks nod for intranasal vaccine as 3rd Dose

India Today 2021-12-20

Views 1.2K

Bharat Biotech seeks approval for Phase 3 clinical trials of its intranasal vaccine, a first of its kind in India. It has recommended nasal vaccine for booster dose. Bharat Biotech is the second company to submit an application for Phase 3 trial for the third dose in India.

Share This Video


Download

  
Report form
RELATED VIDEOS